Monthly Archives: May 2013

Featured Stories

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

Tentative Ohio Fracking Regulations Criticized as too Lax

Lawmakers in Ohio have tentatively passed new regulations governing hydraulic fracturing (fracking) drilling but they’ve immediately been criticized for being too favorable to the natural gas and oil industries.

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Death in Those Taking Bactrim with ACE Inhibitors or ARBs

Sudden Death in Those Taking Bactrim Along with ACE Inhibitors or ARBs

Association between sudden death in those given Bactrim while already taking renin-angiotensin system blockers angiotensin receptor blockers (ARBs), heart medications.

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Yale’s Infuse® Bone Graft Study Expected in June

Yale_Infuse_Bone_Graft_study

A Yale University report concerning the bone graft product Infuse® is expected out next month. Device maker, Medtronic, commissioned Yale University researchers to conduct independent studies of its Infuse® bone graft products, allegedly in response to a June 2011 report … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Blood Cancer, Rheumatoid Arthritis Drug, MabThera, Linked to Severe Skin Reactions

Mabthera-Skin-Reactions

Roche Products Limited just issued a letter to healthcare providers in cooperation with the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA) concerning the use of MabThera (rituximab) and severe skin reactions. According to Roche, … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Januvia, Byetta, Other Diabetes Drugs Focus of Controversy

Januvia_Diabetes

Some popular and money making diabetes drugs are at the center of a conflict over disturbing research findings. Although Dr. Peter C. Butler declined to test its then-new diabetes medication, Januvia, he ultimately relented and, in 2008, observed that the … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Supreme Court of New Jersey Centralizes Mirena® IUD Litigation

Mirena_NJ_Supreme_Court

The Supreme Court of New Jersey just reconsidered a prior decision and is centralizing all Mirena® intrauterine device (IUD) litigation in Bergen County, New Jersey. This will enable the process to move more efficiently given that many of the plaintiffs … Continue reading

Posted in Defective Medical Devices, Mirena IUD |

Study: Zyprexa, Other Antipsychotics, Associated with Increased Risks for Torsade de Pointes

Zyprexa_Torsade

A recent study has found that some antipsychotic drugs were associated with increased risks for developing torsade de pointes (TdP), a type of abnormal heart rhythm, and other adverse events. Zyprexa was among the drugs studied. For their research, the … Continue reading

Posted in Pharmaceuticals |

EPA Proposes Stricter Rules over Formaldehyde Exposure

Formaldyhyde-Exposure

The U.S. Environmental Protection Agency (EPA) just proposed two rules to protect Americans from exposure to the harmful chemical, formaldehyde. The rules are consistent with a 2010 Federal law unanimously passed by Congress. The rules ensure that domestically produced or … Continue reading

Posted in Health Concerns, Legal News, Toxic Substances |

Wal-Mart Pleads Guilty to Federal Environmental Crimes, Civil Violations, to Pay More Than $81 Million

Walmart_Pleads_Guilty

Wal-Mart has admitted to violating criminal and civil laws meant to protect water quality and ensure proper handling of hazardous wastes and pesticides, the Environmental Protection Agency (EPA) announced. The retailer pleaded guilty to six counts of violating the Clean … Continue reading

Posted in Health Concerns, Legal News, Toxic Substances |

Experts Question Drugmakers’ Push to Treat Low Testosterone

Low-Testoterone

Drugmakers are lavishing millions of dollars on ads promoting the wonders of testosterone treatment, but they overhype the benefits and underplay the risks, according to Consumer Reports magazine. The print and television ads, primarily for two products, AndroGel and Axiron, … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Study: Pesticide Exposure Increases Risks for Parkinson’s Disease

Pesticide_Exposure

For not the first time, a study suggests a link between Parkinson’s disease and pesticide exposure. Parkinson’s disease is a progressive, degenerative central nervous system disorder that typically affects motor skills and speech, among other functions and, while not fatal, … Continue reading

Posted in Health Concerns, Paraquat, PCBs, Perchlorate, Toxic Substances |

Yale’s Medtronic Reporting Expected Next Month

Yale_Medtronic_Reporting

As the fallout from a conflict-of-interest scandal continues, drug maker Medtronic, announced in its fiscal fourth-quarter earnings report that the results from a long-awaited Yale review are expected to be published next month. Medtronic has been the focus of a … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.